Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia;Genótipos de vírus de papiloma humano em carcinoma de células escamosas de cabeça e pescoço na Colômbia

Brazilian Journal of Otorhinolaryngology

Volumn 79, Issue 3, 2013, Pages 375-381

  Quintero, Katherine ^a   Giraldo, Gabriel A ^a   Uribe, Mary L ^b   Baena, Armando ^a   Lopez, Carolina ^a   Alvarez, Efrain ^a   Sanchez, Gloria I ^a  

^a University of Antoquia   (Colombia)

^b UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Head and neck neoplasms; Laryngeal neoplasms; Oropharyngeal neoplasms; Papillomavirus infections; Papillomavirus vaccines

Indexed keywords

EID: 84878853827     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.5935/1808-8694.20130065     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917. http://dx.doi.org/10.1002/ijc.25516 PMid:21351269
2. Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer. Prev 2008;17(4):340-344. http://dx.doi.org/10.1097/CEJ.0b013e3282f75e91 PMid:18562959
3. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al.; WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10(4):321-322. http://dx.doi.org/10.1016/ S1470-2045(09)70096-8
4. Herrero R. Chapter 7: Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst. Monogr. 2003(31):47-51. http://dx.doi.org/10.1093/oxfordjournals.jncimonographs.a003482 PMid:12807945
5. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyn-geal cancer. N Engl J Med. 2007;356(19):1944-1956. http://dx.doi. org/10.1056/NEJMoa065497 PMid:17494927
6. Pintos J, Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, et al. Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral Oncol. 2008;44(3):242-50. http://dx.doi.org/10.1016/j.oraloncology.2007.02.005 PMid:17467327
7. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balaram P, et al.; IARC Multicenter Oral Cancer Study Group. Human papillo-mavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95(23):1772-83. http://dx.doi.org/10.1093/jnci/djg107 PMid:14652239
8. Chaturvedi AK. Epidemiology and clinical aspects of HPV in head and neck cancers. Head Neck Pathol. 2012;6 Suppl 1:S16-S24. http:// dx.doi.org/10.1007/s12105-012-0377-0 PMid:22782220
9. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012. [Epub ahead of print].
10. Heck JE, Berthiller J, Vaccarella S, Winn DM, Smith EM, Shan'gina O, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol. 2010;39(1):166-81. http://dx.doi.org/10.1093/ije/dyp350 PMid:20022926 PMCid:2817092
11. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100(6):407-420. http://dx.doi.org/10.1093/jnci/djn025 PMid:18334711
12. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillo-mavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-475. http://dx.doi.org/10.1158/1055-9965.EPI-04-0551 PMid:15734974
13. Forte T, Niu J, Lockwood GA, Bryant HE. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oro-pharyngeal cancer in Canada, 1992-2009. Cancer Causes Control. 2012;23(8):1343-1348. http://dx.doi.org/10.1007/s10552-012-0013-z PMid:22718355
14. Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M. Human papillo-mavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol. 2012;6 Suppl 1:S104-20. http:// dx.doi.org/10.1007/s12105-012-0368-1 PMid:22782230
15. Wang XI, Thomas J, Zhang S. Changing trends in human papillo-mavirus-associated head and neck squamous cell carcinoma. Ann Diagn Pathol. 2012;16(1):7-12. http://dx.doi.org/10.1016/j.anndiagpa-th.2011.07.003 PMid:22001331
16. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009;21(3):194-200. http://dx.doi.org/10.1097/CCO.0b013e32832a68ca PMid:19363341
17. Lambert R, Sauvaget C, de Camargo Cancela M, Sankaranarayanan R. Epidemiology of cancer from the oral cavity and oropharynx. Eur J Gastroenterol Hepatol. 2011;23(8):633-641. http://dx.doi.org/10.1097/MEG.0b013e3283484795 PMid:21654320
18. Ribeiro KB, Levi JE, Pawlita M, Koifman S, Matos E, Eluf-Neto J, et al. Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011;40(2):489-502. http://dx.doi.org/10.1093/ije/dyq249 PMid:21224273
19. De Carvalho N, Teixeira J, Roteli-Martins CM, Naud P, De Borba P, Zahaf T, et al. Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women. Vaccine. 2010;28(38):6247-6255. http://dx.doi.org/10.1016/j. vaccine.2010.07.007 PMid:20643092
20. FUTURE I/II Study Group,Dillner J, Kjaer SK, Wheeler CM, Sigur-dsson K, Iversen OE, Hernandez-Avila M, et al. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial. BMJ. 2010;341:c3493. http://dx.doi.org/10.1136/bmj.c3493 PMid:20647284 PMCid:2907480
21. Fairley CK, Hocking JS, Gurrin LC, Chen MY, Donovan B, Bradshaw CS. Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect. 2009;85(7):499-502. http://dx.doi.org/10.1136/sti.2009.037788 PMid:19837728
22. Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008;113(10 Suppl):3036-3046. http://dx.doi. org/10.1002/cncr.23764 PMid:18980286
23. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5? PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillo-mavirus genotypes. J Clin Microbiol. 2002;40(3):779-787. http://dx.doi. org/10.1128/JCM.40.3.779-787.2002 PMid:11880393 PMCid:120256
24. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996;34(3):745-747. PMid:8904451 PMCid:228883
25. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, de Sanjose S, Kjaer SK, et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine. 2008;26 (Suppl 10):K17-K28. http://dx.doi.org/10.1016/j.vacci-ne.2008.06.021 PMid:18847554
26. Johnson-Obaseki S, McDonald JT, Corsten M, Rourke R. Head and neck cancer in Canada: trends 1992 to 2007. Otolaryngol Head Neck Surg. 2012;147(1):74-78. http://dx.doi.org/10.1177/0194599812437332 PMid:22328702
27. Lewis JS Jr, Khan RA, Masand RP, Chernock RD, Zhang Q, Al-Naief NS, et al. Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma - a prospective cohort and interobserver variability study. Histopathology. 2012;60(3):427-436. http://dx.doi. org/10.1111/j.1365-2559.2011.04092.x PMid:22211374
28. Schiffman M, Safaeian M, Wentzensen N. The use of human papillo-mavirus seroepidemiology to inform vaccine policy. Sex Transm Dis. 2009;36(11):675-679. http://dx.doi.org/10.1097/OLQ.0b013e3181bce102 PMid:19773679
29. Kreimer AR, Clifford GM, Snijders PJ, Castellsagué X, Meijer CJ, Pawlita M, et al. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int J Cancer. 2005;115(2):329-332. http://dx.doi.org/10.1002/ijc.20872 PMid:15688391
30. Odida M, de Sanjose S, Sandin S, Quiros B, Alemany L, Lloveras B, et al. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer. 2010;5:15. http://dx.doi.org/10.1186/1750-9378-5-15 PMid:20846370 PMCid:2954863
31. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLO-BOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. [Acessed 2012 Oct 10]. Available from: http://globocan.iarc.fr/
32. Mackay J, Ericksen M. The demographics of Tobacco. In: Part six: Table A. Geneva: World Health Organization;2002. p.94-101.
33. Shafey O, Eriksen M, Ross H, Mackay J. The tobacco atlas, 2009. [Acessed 2011 May 21]. Available from: http://www.tobaccoatlas.org/